Evaluation of Tumor Resection Guided by Intraoperative Indocyanine Green Dye Fluorescence Angiography in Patients With Sarcoma

Launched by MAYO CLINIC · May 7, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at how well a special dye called indocyanine green, used during surgery, can help doctors see if all of a tumor has been removed completely in patients with bone or soft tissue sarcoma. The goal is to make sure there are no remaining cancer cells at the edges of the tissue that was taken out, which is important for the best chance of recovery.

To participate in this study, you need to be at least 18 years old and have a confirmed diagnosis of bone or soft tissue sarcoma that requires surgery. Unfortunately, if you have chronic kidney disease or a serious allergic reaction to dyes, you wouldn't be eligible for this trial. If you join, you can expect to undergo the usual surgery along with the use of this dye, which helps the surgical team ensure they are removing the tumor effectively. The trial is currently recruiting participants, so if you or someone you know fits the criteria, it could be a great opportunity to help advance treatment for sarcoma.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with biopsy-proven bone or soft tissue sarcoma undergoing resection
• Exclusion Criteria:
• • \* Age less than 18
• • Chronic kidney disease
• • Anaphylaxis to dyes